NDC00069-3140-19 — AZITHROMYCIN FOR ORAL SUSPENSION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00069-3140-19: AZITHROMYCIN FOR ORAL SUSPENSION.

AZITHROMYCIN FOR ORAL SUSPENSION. Key specifications include administration: ORAL, special_features: 200MG PER 5ML, 30ML AFTER RECONSTRUCTION, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, part_name_assigned_by_controlling_agency: AZITHROMYCIN FOR ORAL SUSPENSION USP (ZITHROMAX) 200MG PER 5ML 30ML, american_hospital_formulary_service_classification_number: 081212. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-505-3359, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00069-3140-19

NSN: 6505-01-505-3359
FSC: 6505 — Drugs and Biologicals
CAGE: 86491 — PFIZER INC (USA)

SPECIFICATIONS

administration	ORAL
special_features	200MG PER 5ML, 30ML AFTER RECONSTRUCTION
primary_container_type	BOTTLE
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
part_name_assigned_by_controlling_agency	AZITHROMYCIN FOR ORAL SUSPENSION USP (ZITHROMAX) 200MG PER 5ML 30ML
american_hospital_formulary_service_classification_number	081212
NSN	6505-01-505-3359

COMPONENT DIAGRAM

KEY FEATURES

•

ADMINISTRATION: ORAL

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: BOTTLE

•

AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081212

TECHNICAL CHARACTERISTICS

ADMINISTRATION	ORAL
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	BOTTLE
SPECIAL FEATURES	200MG PER 5ML, 30ML AFTER RECONSTRUCTION
PART NAME ASSIGNED BY CONTROLLING AGENCY	AZITHROMYCIN FOR ORAL SUSPENSION USP (ZITHROMAX) 200MG PER 5ML 30ML
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER	081212

SUBSTITUTES & CROSS-REFERENCES 3

NDC24658-0708-34Same NSN cross-reference

Same NSN cross-reference

Also cataloged under this NSN

03-0027Reference document

Same NSN cross-reference

Reference document — Secondary reference

ZITHROMAXReference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC00069-3140-19?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00069-3140-19?

NDC00069-3140-19 is a AZITHROMYCIN FOR ORAL SUSPENSION.

What parts can replace NDC00069-3140-19?

There are 3 known substitutes for NDC00069-3140-19: NDC24658-0708-34, 03-0027, ZITHROMAX. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00069-3140-19?

NDC00069-3140-19 is cataloged in the U.S. Government catalog under NSN 6505-01-505-3359. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00069-3140-19 — AZITHROMYCIN FOR ORAL SUSPENSION

Request a Quote — NDC00069-3140-19